Immunophotonics is pleased to announce that Robert Arch, Ph.D., Chief Executive Officer and President of Immunophotonics, will be a featured speaker at BioFuture 2026, taking place October 27-28, 2026, in New York City.

Dr. Arch will participate in the Spotlight Panel, “Beyond the Cure: The Brave New World of Revolutionary Cancer Therapeutics,” where he will join fellow industry leaders to discuss emerging innovations, advances in cancer treatment, and the evolving future of oncology.

BioFuture brings together innovators, investors, and industry stakeholders from across the biopharmaceutical ecosystem to explore advancements that are shaping the future of healthcare and improving outcomes for patients.

Immunophotonics looks forward to participating in these important discussions and connecting with leaders who share a commitment to advancing innovative cancer therapies.